Hikma Pharmaceuticals PLC (HIK)

2,367.00
+53.00(+2.29%)
  • Volume:
    302,807
  • Bid/Ask:
    2,240.00/2,670.00
  • Day's Range:
    2,330.00 - 2,373.00

HIK Overview

Prev. Close
2,314
Day's Range
2,330 - 2,373
Revenue
2.34B
Open
2,331
52 wk Range
2,086.49 - 2,768
EPS
1.29
Volume
302,807
Market Cap
5.46B
Dividend (Yield)
37.04 (1.60%)
Average Vol. (3m)
415,694
P/E Ratio
17.94
Beta
0.23
1-Year Change
-3.86%
Shares Outstanding
230,771,404
Next Earnings Date
Aug 06, 2021
What is your sentiment on Hikma Pharmaceuticals PLC?
or
Market is currently closed. Voting is open during market hours.

Hikma Pharmaceuticals PLC News

Hikma Pharmaceuticals PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyNeutralBuy
SummaryStrong BuyStrong BuyStrong BuyNeutralBuy

Hikma Pharmaceuticals PLC Company Profile

Hikma Pharmaceuticals PLC Company Profile

Employees
8681

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 300 products in different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.

Read More
  • Too high price today .low volume
    0
    • What happened for it to jump 10%
      0
      • i think the company is doing well so it is a good investment
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.